Hepatitis C virus genotype diversity among intravenous drug users in Yunnan Province, Southwestern China

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Zhang, Zhihui ^a   Yao, Yufeng ^a   Wu, Wenlong ^b   Feng, Ruilin ^b   Wu, Zhongxiang ^a   Cun, Wei ^a   Dong, Shaozhong ^a  

^a INSTITUTE OF MEDICAL BIOLOGY   (China)

^b Kunming Center for Disease Control and Prevention   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CHINA; CONTROLLED STUDY; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOMIC FRAGMENT; GEOGRAPHIC DISTRIBUTION; HEPATITIS C VIRUS; HEPATITIS C VIRUS GENOTYPE 1; HEPATITIS C VIRUS GENOTYPE 3; HEPATITIS C VIRUS GENOTYPE 6; HEPATITIS C VIRUS SUBTYPE 1A; HEPATITIS C VIRUS SUBTYPE 1B; HEPATITIS C VIRUS SUBTYPE 3A; HEPATITIS C VIRUS SUBTYPE 3B; HEPATITIS C VIRUS SUBTYPE 6A; HEPATITIS C VIRUS SUBTYPE 6N; HEPATITIS C VIRUS SUBTYPE 6U; HEPATITIS C VIRUS SUBTYPE 6V; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SPECIES DISTRIBUTION; SPECIES DOMINANCE; VIRUS IDENTIFICATION; COMPLICATION; DRUG USE; GENE FREQUENCY; GENETICS; GENOTYPE; HEPACIVIRUS; HEPATITIS C; ISOLATION AND PURIFICATION; PHYLOGENY; PREVALENCE; STATISTICS AND NUMERICAL DATA; SUBSTANCE ABUSE; VIROLOGY;

VIRUS RNA;

CHINA; DRUG USERS; GENE FREQUENCY; GENETIC VARIATION; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; PHYLOGENY; PREVALENCE; RNA, VIRAL; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84893058008     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082598     Document Type: Article

References (20)

1. Simmonds P (2004) Genetic diversity and evolution of hepatitis C virus-15 years on. J Gen Virol 85: 3173-3188.
2. Hoofnagle JH (2002) Course and outcome of hepatitis C. Hepatology 36: S21-29.
3. Moradpour D, Penin F, Rice CM (2007) Replication of hepatitis C virus. Nat Rev Microbiol 5: 453-463.
4. Sy T, Jamal MM (2006) Epidemiology of hepatitis C virus (HCV) infection. International journal of medical sciences 3: 41.
5. Bao Y-p, Liu Z-m, Lu L (2010) Review of HIV and HCV infection among drug users in China. Current Opinion in Psychiatry 23: 187-194.
6. Zhang C, Wu N, Liu J, Ge Q, Huang Y, et al. (2011) HCV subtype characterization among injection drug users: implication for a crucial role of Zhenjiang in HCV transmission in China. PLoS One 6: e16817.
7. Ye Y, Yan YS, Chen G, Yan PP, Zheng WX, et al. (2013) Molecular epidemiology of hepatitis C virus among different groups of people in the province of Fujian, China. Arch Virol 158: 611-618.
8. Xia X, Lu L, Tee KK, Zhao W, Wu J, et al. (2008) The unique HCV genotype distribution and the discovery of a novel subtype 6u among IDUs co-infected with HIV-1 in Yunnan, China. J Med Virol 80: 1142-1152.
9. Tan Y, Wei QH, Chen LJ, Chan PC, Lai WS, et al. (2008) Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China. PLoS One 3: e3608.
10. Lwin AA, Shinji T, Khin M, Win N, Obika M, et al. (2007) Hepatitis C virus genotype distribution in Myanmar: Predominance of genotype 6 and existence of new genotype 6 subtype. Hepatol Res 37: 337-345.
11. Fu Y, Qin W, Cao H, Xu R, Tan Y, et al. (2012) HCV 6a prevalence in Guangdong province had the origin from Vietnam and recent dissemination to other regions of China: phylogeographic analyses. PloS one 7: e28006.
12. Du H, Qi Y, Hao F, Huang Y, Mao L, et al. (2012) Complex patterns of HCV epidemic in Suzhou: evidence for dual infection and HCV recombination in East China. J Clin Virol 54: 207-212.
13. Zhou Y-H, Yao Z-H, Liu F-L, Li H, Jiang L, et al. (2012) High Prevalence of HIV, HCV, HBV and Co-Infection and Associated Risk Factors among Injecting Drug Users in Yunnan Province, China. PloS one 7: e42937.
14. Murphy DG, Willems B, Deschênes M, Hilzenrat N, Mousseau R, et al. (2007) Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 59 untranslated region sequences. Journal of clinical microbiology 45: 1102-1112.
15. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Molecular biology and evolution 28: 2731-2739.
16. Dunford L, Carr MJ, Dean J, Waters A, Nguyen LT, et al. (2012) Hepatitis C virus in Vietnam: high prevalence of infection in dialysis and multi-transfused patients involving diverse and novel virus variants. PLoS One 7: e41266.
17. Garten RJ, Lai S, Zhang J, Liu W, Chen J, et al. (2004) Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int J Epidemiol 33: 182-188.
18. Liu JY, Lin HH, Liu YC, Lee SS, Chen YL, et al. (2008) Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan. Clin Infect Dis 46: 1761-1768.
19. Pybus OG, Cochrane A, Holmes EC, Simmonds P (2005) The hepatitis C virus epidemic among injecting drug users. Infection, Genetics and Evolution 5: 131-139.
20. Pybus OG, Barnes E, Taggart R, Lemey P, Markov PV, et al. (2009) Genetic history of hepatitis C virus in East Asia. J Virol 83: 1071-1082.